Momenta Pharma (MNTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Sales | 23,868 | 75,589 | 138,882 | 109,619 | 89,650 |
| Gross Profit | 23,868 | 75,589 | 138,882 | 109,619 | 89,650 |
| Operating Expenses | 321,959 | 256,916 | 231,433 | 184,346 | 174,084 |
| Operating Income | -298,091 | -181,327 | -92,551 | -74,727 | -84,434 |
| Interest Expense | 2,018 | 0 | 0 | 0 | 0 |
| Other Income | 10,054 | 5,266 | 4,455 | 53,724 | 1,121 |
| Pre-tax Income | -290,055 | -176,061 | -88,096 | -21,003 | -83,313 |
| Net Income Continuous | -290,055 | -176,061 | -88,096 | -21,003 | -83,313 |
| Net Income | $-290,055 | $-176,061 | $-88,096 | $-21,003 | $-83,313 |
| EPS Basic Total Ops | -2.92 | -2.26 | -1.20 | -0.31 | -1.32 |
| EPS Basic Continuous Ops | -2.92 | -2.26 | -1.20 | -0.31 | -1.32 |
| EPS Diluted Total Ops | -2.92 | -2.26 | -1.20 | -0.31 | -1.32 |
| EPS Diluted Continuous Ops | -2.92 | -2.26 | -1.20 | -0.31 | -1.32 |
| EPS Diluted Before Non-Recurring Items | -3.03 | -2.03 | -1.20 | -0.31 | -1.32 |
| EBITDA(a) | $-287,056 | $-170,695 | $-83,208 | $-65,010 | $-74,396 |